Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels - Concepedia

Concepedia

Publication | Open Access

Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels

DOI Full Paper Access

41

Citations

18

References

2010

Year

Yuki Horiuchi, Satoshi Hirayama, Satoshi Soda, Utako Seino, Mika Kon, Tsuyoshi Ueno, Mayumi Idei, Osamu Hanyu, Takashi Tsuda, Hirotoshi Ohmura,

Journal of Atherosclerosis and Thrombosis

Abstract

Statin therapy reduces inflammatory markers in hypercholesterolemic patients, and this anti-inflammatory action is limited to patients whose inflammatory markers are elevated at baseline.

References

	Year	Citations
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Anders Olsson, John J.V. McMurray, G Thorgeirsson, The Lancet Cardiovascular DiseaseHealth PolicyHyperlipidemiaDyslipidemiaPreventive Cardiology	1994	8.5K
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé, New England Journal of Medicine	1996	7.5K
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia James Shepherd, Stuart M. Cobbe, Ian Ford, New England Journal of Medicine	1995	7.5K
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, New England Journal of Medicine	2008	6.5K
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events Paul M. Ridker, Nader Rifai, Lynda Rose, New England Journal of Medicine	2002	3.6K
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. William P. Castelli, Robert J. Garrison, Peter W.F. Wilson, PubMed HypertensionHyperlipidemiaCoronary Artery DiseaseBody CompositionClinical Epidemiology	1986	2.3K
Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease J. Tuomilehto, Gabriele Vidgrén, L. Toivanen, The Lancet Metabolic SyndromeAutoimmune DiseaseInsulin-dependent Diabetes MellitusDiabetesImmunology	1994	1.7K
Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels Paul M. Ridker, Nader Rifai, Marc A. Pfeffer, Circulation	1998	1.4K
High-Sensitivity C-Reactive Protein Paul M. Ridker Circulation	2001	1.4K
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial Haruo Nakamura, Kikuo Arakawa, Hiroshige Itakura, The Lancet Non-pharmacological InterventionPrimary PreventionPreventive MedicineCardiovascular DiseaseHealth Policy	2006	949

Page 1